Page last updated: 2024-10-27

fluspirilene and Somatoform Disorders

fluspirilene has been researched along with Somatoform Disorders in 3 studies

Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research Excerpts

ExcerptRelevanceReference
"A group of 82 nonselected patients with the leading symptom "anxiety" as part of psychoreactive disturbances was included in a study comparing the effectiveness of fluspirilene and bromazepam."9.05[Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. ( Thilmann, J, 1983)
"A group of 82 nonselected patients with the leading symptom "anxiety" as part of psychoreactive disturbances was included in a study comparing the effectiveness of fluspirilene and bromazepam."5.05[Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. ( Thilmann, J, 1983)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thilmann, J1
Schwab, H1
Pein, R1
Wittenbeck, K1
Hassel, P1

Trials

2 trials available for fluspirilene and Somatoform Disorders

ArticleYear
[Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam].
    Fortschritte der Medizin, 1983, Oct-06, Volume: 101, Issue:37

    Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Bromazepam; Clinical Trials as Topic; Female; Fluspirilen

1983
Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances.
    Pharmacopsychiatry, 1985, Volume: 18, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Attention; Bromazepam; Dose-Response Relatio

1985

Other Studies

1 other study available for fluspirilene and Somatoform Disorders

ArticleYear
[Psychovegetative disorders in gynecology. Treatment with Imap 1.5 mg].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1982, Dec-20, Volume: 58, Issue:35-36

    Topics: Adolescent; Adult; Aged; Female; Fluspirilene; Genital Diseases, Female; Humans; Middle Aged; Psycho

1982